Cantab Pharmaceuticals Research Limited
Records under this name other than patents Cantab Pharmaceuticals Research Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cantab Pharmaceuticals Research Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,054,127 | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same Formerly held Term ended Term ended Jun 27, 2017 · USPTO record | Term ended | Term ended Jun 27, 2017 | USPTO record |
| US 6,541,009 | Viral vaccines Formerly held Lapsed on the fee record Ended Apr 1, 2015 · USPTO record | Lapsed on the fee record | Ended Apr 1, 2015 | USPTO record |
| US 6,287,557 | Methods of gene therapy using herpes viral vectors expressing GM-CSF Lapsed on the fee record Ended Sep 11, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 11, 2013 | USPTO record |
| US 6,267,967 | Virus preparations and methods Lapsed on the fee record Ended Jul 31, 2013 · USPTO record | Lapsed on the fee record | Ended Jul 31, 2013 | USPTO record |
| US 6,258,362 | Stabilization of herpes virus preparations Lapsed on the fee record Ended Jul 10, 2013 · USPTO record | Lapsed on the fee record | Ended Jul 10, 2013 | USPTO record |
| US 6,123,948 | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation Lapsed on the fee record Ended Sep 26, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 26, 2012 | USPTO record |
| US 7,374,768 | Viral vaccines Formerly held Lapsed on the fee record Ended May 20, 2012 · USPTO record | Lapsed on the fee record | Ended May 20, 2012 | USPTO record |
| US 6,344,445 | Herpes virus vectors and their uses Formerly held Lapsed on the fee record Ended Feb 5, 2010 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2010 | USPTO record |
| US 5,665,362 | Viral vaccines Term ended Term ended no later than Sep 9, 2017 · Low confidence | Term ended | Term ended no later than Sep 9, 2017 | Low confidence |
| US 5,719,054 | Recombinant virus vectors encoding human papillomavirus proteins Term ended Term ended no later than Feb 17, 2018 · Low confidence | Term ended | Term ended no later than Feb 17, 2018 | Low confidence |